Trial intelligence / Profile preview

mOPV1 and fIPV in Infants

NCT03722004Phase 4Completed

Sponsor
Centers for Disease Control and Prevention
Start
Dec 2018
Primary completion
Dec 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of monovalent oral polio vaccine type 1 in poliomyelitis, sponsored by Centers for Disease Control and Prevention. Started Dec 2018; status: completed.

02

Drugs

monovalent oral polio vaccine type 1
03

Conditions

poliomyelitis

Beyond the preview

Go deeper on NCT03722004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03722004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call